Skip to content

A study on the effect of bitter gourd (Momordica charantia) containing drink on blood glucose level in human.

A study on the effect of bitter gourd (Momordica charantia) containing drink on blood glucose level in human. - A study on the effect of bitter gourd (Momordica charantia) containing drink on blood glucose level in human.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016221
Enrollment
20
Registered
2015-02-01
Start date
2014-10-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high normal blood glucose and borderline hyperglycemia

Interventions

cellulose bitter gourd beverage, low dose (cultivar A, the amount of bitter gourd=50g) bitter gourd beverage, high dose (cultivar A, the amount of bitter gourd=100g) bitter gourd beverage, low dose

Sponsors

Suntory Global Innovation Center Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Healthy males and females aged 20 to less than 65 years old. (2)Subjects whose fasting blood glulose levels are ranged from 100mg/dL to less than 126 mg/dL. (3)Subjects who can make self-judgment and are voluntarily giving written informed consent.

Exclusion criteria

Exclusion criteria: (1)Subjects who take continuous medical treatment. (2)Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting the test results. (3)Subjects who have contracted or are contracting heart disease, liver disease, kidney disease and digestive disease. (4)Subjects who are pregnant or have possibility to bocome pregnant or planning to become pregnant during the study or breast-feeding woman. (5)Subjects who drink alcohol a lot (6)Subjects who have an extremely irregular diet habit or alternative work schedule or work on midnight shift (7)Subjects who have allergic reaction to drug medicine and food. (8)Subjects who have systolic blood pressure less than 90 mmHg. (9)Subjects who donated 200 mL of blood and/or blood components within the last one month prior to the current study. (10)Male subjects who donated 400 mL of blood within the last three months prior to the current study. (11)Female subjects who donated 400 mL of blood within the last four months prior to the current study. (12)Male subjects whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added. (13)Female subjects whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added. (14)Subjects who are participating in other clinical studies for drug medicine or food, or who finished clinical study within four weeks, or who are planning to participate in other clinical study. (15)Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Area under the curve of blood glucose level after ingestion of rice

Secondary

MeasureTime frame
Blood glucose level at each blood sampling time after ingestion of rice

Countries

Japan

Contacts

Public ContactHiroshi Watanabe

Suntory Global Innovation Center Limited Innovation Development Department

H_Watanabe@suntory.co.jp075-962-7599

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026